{"name":"Frederick Schmitt","slug":"frederick-schmitt","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"alphatocopherol","genericName":"alphatocopherol","slug":"alphatocopherol","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"alphatocopherol","genericName":"alphatocopherol","slug":"alphatocopherol","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPYzhTMWRRVURRSWdWZ01Vc0VkQWQzcmVPVzU2aEZva1JldWtLYnV4MUx6aHYtdTh6b05CR2Etc3NELTN6aU9VbnR1Nm1YWXVMdkY1NjAtdWQwNmphNmZwQUtzVWJPaUFBYTU2TWVySllhX1FoTE9jeVY5ZVM4aE9JUHNNZDFrdXBUaVY5ZU5FTGVzZkExMEEyaENiRjR4c1dNQ21EaVBONlF4ZGxfSXhwX1VVZ2hFLTRqaEdyag?oc=5","date":"2022-01-13","type":"pipeline","source":"GeekWire","summary":"Juno co-founder launches ambitious new startup with Fred Hutch colleagues to treat cancer - GeekWire","headline":"Juno co-founder launches ambitious new startup with Fred Hutch colleagues to treat cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBoQmV2UnBXUzZLSmxMaUpNTmo3dzdVeUl5VVYtWEtaNzRTUGlFTGFWeVduTE9XdGdjVFJOaGVQcnpPakFTeFBzQ0tVSE9OUmY3bjA4U2o1UDVmZ1ZRYjNz?oc=5","date":"2017-07-03","type":"regulatory","source":"NEJM","summary":"Memantine in Moderate-to-Severe Alzheimer's Disease - NEJM","headline":"Memantine in Moderate-to-Severe Alzheimer's Disease","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}